Jun 09, 2022 / 03:40PM GMT
John Charles Kreger - William Blair & Company L.L.C., Research Division - Interim Director of Research
Thank you all for joining us. I'm John Kreger, the analyst at Blair that covers Charles River. By way of disclosures, please see williamblair.com for any and all conflicts that we have. Logistically, as we've done all week, we're going to do a 30-minute presentation here in the room. And then anyone that wants to take part in Q&A, that will be in Richardson upstairs on the second floor.
Presenting will be Jim Foster, the CEO. Thank you, Jim, for coming. And then we also have Flavia Pease, the brand-new CFO, sitting here in the front row; and also Todd Spencer, running IR. They'll both be available for Q&A upstairs.
So with that, Jim, I'll turn it over to you.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thank you, John. Always a pleasure to be at this conference. Safe harbor and Reg G statements.
So we've got some great stats. We worked on 85% of the drugs approved in
Charles River Laboratories International Inc at William Blair Growth Stock Conference Transcript
Jun 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers